Naturally occurring hepatitis C virus subgenomic deletion mutants replicate efficiently in Huh-7 cells and are trans-packaged in vitro to generate infectious defective particles

Journal of Virology

Volumn 83, Issue 18, 2009, Pages 9079-9093

  Pacini, Laura ^a   Graziani, Rita ^a   Bartholomew, Linda ^a   De Francesco, Raffaele ^b   Paonessa, Giacomo ^a  

^a IRBM   (Italy)

^b Istituto Nazionale di Genetica Molecolare   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; CORE PROTEIN; GLYCOPROTEIN E1; NONSTRUCTURAL PROTEIN 2; POLYPROTEIN; STRUCTURAL PROTEIN; VIRUS RNA;

ARTICLE; CELL LINE; CONTROLLED STUDY; DELETION MUTANT; DISSECTION; DNA PACKAGING; GENE DELETION; GENE STRUCTURE; GENETIC COMPLEMENTATION; GENETIC TRANSFECTION; HELPER CELL; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; IN VITRO STUDY; LIFE CYCLE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; VIRUS GENOME; VIRUS PARTICLE; VIRUS REPLICATION; WILD TYPE;

CELL LINE; GENOME, VIRAL; HEPACIVIRUS; HUMANS; RNA, VIRAL; SEQUENCE DELETION; VIRAL STRUCTURAL PROTEINS; VIRION; VIRUS ASSEMBLY; VIRUS REPLICATION;

HEPATITIS C VIRUS;

EID: 69449090752     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.00308-09     Document Type: Article

References (57)

1. Alter, M. J. 2007. Epidemiology of hepatitis C virus infection. World J. Gastroenterol. 13:2436-2441.
2. Appel, N., U. Herian, and R. Bartenschlager. 2005. Efficient rescue of hepatitis C virus RNA replication by trans-complementation with nonstructural protein 5A. J. Virol. 79:896-909. (Pubitemid 40053873)
3. Appel, N., M. Zayas, S. Miller, J. Krijnse-Locker, T. Schaller, P. Friebe, S. Kallis, U. Engel, and R. Bartenschlager. 2008. Essential role of domain III of nonstructural protein 5A for hepatitis C virus infectious particle assembly. PLoS Pathog. 4:e1000035. (Pubitemid 351631086)
4. Barazani, Y., J. R. Hiatt, M. J. Tong, and R. W. Busuttil. 2007. Chronic viral hepatitis and hepatocellular carcinoma. World J. Surg. 31:1243-1248.
5. Bernardin, F., S. L. Stramer, B. Rehermann, K. Page-Shafer, S. Cooper, D. R. Bangsberg, J. Hahn, L. Tobler, M. Busch, and E. Delwart. 2007. High levels of subgenomic HCV plasma RNA in immunosilent infections. Virology 365:446-456. (Pubitemid 47223319)
6. Blight, K. J., J. A. McKeating, and C. M. Rice. 2002. Highly permissive cell lines for subgenomic and genomic hepatitis C virus RNA replication. J. Virol. 76:13001-13014.
7. Blonski, W., and K. R. Reddy. 2008. Hepatitis C virus infection and hepatocellular carcinoma. Clin. Liver Dis. 12:661-674.
8. Boni, S., J. P. Lavergne, S. Boulant, and A. Cahour. 2005. Hepatitis C virus core protein acts as a trans-modulating factor on internal translation initiation of the viral RNA. J. Biol. Chem. 280:17737-17748.
9. de Felipe, P., G. A. Luke, L. E. Hughes, D. Gani, C. Halpin, and M. D. Ryan. 2006. E unum pluribus: multiple proteins from a self-processing polyprotein. Trends Biotechnol. 24:68-75.
10. Drummer, H. E., A. Maerz, and P. Poumbourios. 2003. Cell surface expression of functional hepatitis C virus E1 and E2 glycoproteins. FEBS Lett. 546:385-390. (Pubitemid 36782444)
11. Duvet, S., A. Op De Beeck, L. Cocquerel, C. Wychowski, R. Cacan, and J. Dubuisson. 2002. Glycosylation of the hepatitis C virus envelope protein E1 occurs posttranslationally in a mannosylphosphoryldolichol-deficient CHO mutant cell line. Glycobiology 12:95-101. (Pubitemid 34428932)
12. Everson, G. T. 2005. Management of cirrhosis due to chronic hepatitis C. J. Hepatol 42(Suppl.):S65-S74. (Pubitemid 40364605)
13. Friebe, P., and R. Bartenschlager. 2002. Genetic analysis of sequences in the 3′ nontranslated region of hepatitis C virus that are important for RNA replication. J. Virol. 76:5326-5338. (Pubitemid 34517883)
14. Friebe, P., V. Lohmann, N. Krieger, and R. Bartenschlager. 2001. Sequences in the 5′ nontranslated region of hepatitis C virus required for RNA replication. J. Virol. 75:12047-12057. (Pubitemid 33115877)
15. Hollinger, F. B. 1999. Factors contributing to the evolution and outcome of cirrhosis in hepatitis C. Clin. Liver Dis. 3:741-755.
16. Iwai, A., H. Marusawa, Y. Takada, H. Egawa, K. Ikeda, M. Nabeshima, S. Uemoto, and T. Chiba. 2006. Identification of novel defective HCV clones in liver transplant recipients with recurrent HCV infection. J. Viral Hepat. 13:523-531. (Pubitemid 44100403)
17. Jin, D. Y. 2007. Molecular pathogenesis of hepatitis C virus-associated hepatocellular carcinoma. Front. Biosci. 12:222-233.
18. Jirasko, V., R. Montserret, N. Appel, A. Janvier, L. Eustachi, C. Brohm, E. Steinmann, T. Pietschmann, F. Penin, and R. Bartenschlager. 2008. Structural and functional characterization of nonstructural protein 2 for its role in hepatitis C virus assembly. J. Biol. Chem. 283:28546-28562.
19. Jones, C. T., C. L. Murray, D. K. Eastman, J. Tassello, and C. M. Rice. 2007. Hepatitis C virus p7 and NS2 proteins are essential for production of infectious virus. J. Virol. 81:8374-8383. (Pubitemid 47242811)
20. Kageyama, S., D. M. Agdamag, E. T. Alesna, P. S. Leano, A. M. Heredia, I. P. Abellanosa-Tac-An, L. D. Jereza, T. Tanimoto, J. Yamamura, and H. Ichimura. 2006. A natural inter-genotypic (2b/1b) recombinant of hepatitis C virus in the Philippines. J. Med. Virol. 78:1423-1428.
21. Kalinina, O., H. Norder, S. Mukomolov, and L. O. Magnius. 2002. A natural intergenotypic recombinant of hepatitis C virus identified in St. Petersburg. J. Virol. 76:4034-4043.
22. Kato, T., T. Date, M. Miyamoto, A. Furusaka, K. Tokushige, M. Mizokami, and T. Wakita. 2003. Efficient replication of the genotype 2a hepatitis C virus subgenomic replicon. Gastroenterology 125:1808-1817. (Pubitemid 37500445)
23. Kolykhalov, A. A., S. M. Feinstone, and C. M. Rice. 1996. Identification of a highly conserved sequence element at the 3′ terminus of hepatitis C virus genome RNA. J. Virol. 70:3363-3371. (Pubitemid 26157317)
24. Kolykhalov, A. A., K. Mihalik, S. M. Feinstone, and C. M. Rice. 2000. Hepatitis C virus-encoded enzymatic activities and conserved RNA elements in the 3′ nontranslated region are essential for virus replication in vivo. J. Virol. 74:2046-2051.
25. Koutsoudakis, G., A. Kaul, E. Steinmann, S. Kallis, V. Lohmann, T. Pietschmann, and R. Bartenschlager. 2006. Characterization of the early steps of hepatitis C virus infection by using luciferase reporter viruses. J. Virol. 80:5308-5320. (Pubitemid 43752776)
26. Kurbanov, F., Y. Tanaka, D. Avazova, A. Khan, F. Sugauchi, N. Kan, D. Kurbanova-Khudayberganova, A. Khikmatullaeva, E. Musabaev, and M. Mizokami. 2007. Detection of hepatitis C virus natural recombinant RF1-2k/1b strain among intravenous drug users in Uzbekistan. Hepatol. Res. 38:457-464.
27. Legrand-Abravanel, F., J. Claudinon, F. Nicot, M. Dubois, S. Chapuy-Regaud, K. Sandres-Saune, C. Pasquier, and J. Izopet. 2007. New natural intergenotypic (2/5) recombinant of hepatitis C virus. J. Virol. 81:4357-4362. (Pubitemid 46586931)
28. Lindenbach, B. D., M. J. Evans, A. J. Syder, B. Wolk, T. L. Tellinghuisen, C. C. Liu, T. Maruyama, R. O. Hynes, D. R. Burton, J. A. McKeating, and C. M. Rice. 2005. Complete replication of hepatitis C virus in cell culture. Science 309:623-626. (Pubitemid 41033648)
29. Ludmerer, S. W., D. J. Graham, M. Patel, K. Gilbert, M. Stahlhut, and D. B. Olsen. 2008. A transient cell-based phenotype assay for hepatitis C NS3/4A protease: application to potency determinations of a novel macrocyclic inhibitor against diverse protease sequences isolated from plasma infected with HCV. J. Virol. Methods 151:301-307.
30. Marrero, C. R., and J. A. Marrero. 2007. Viral hepatitis and hepatocellular carcinoma. Arch. Med. Res. 38:612-620.
31. McMullan, L. K., A. Grakoui, M. J. Evans, K. Mihalik, M. Puig, A. D. Branch, S. M. Feinstone, and C. M. Rice. 2007. Evidence for a functional RNA element in the hepatitis C virus core gene. Proc. Natl. Acad. Sci. USA 104:2879-2884.
32. Miyanari, Y., K. Atsuzawa, N. Usuda, K. Watashi, T. Hishiki, M. Zayas, R. Bartenschlager, T. Wakita, M. Hijikata, and K. Shimotohno. 2007. The lipid droplet is an important organelle for hepatitis C virus production. Nat. Cell Biol. 9:1089-1097.
33. Moreau, I., S. Hegarty, J. Levis, P. Sheehy, O. Crosbie, E. Kenny-Walsh, and L. J. Fanning. 2006. Serendipitous identification of natural intergenotypic recombinants of hepatitis C in Ireland. Virol. J. 3:95. (Pubitemid 44800362)
34. Murray, C. L., C. T. Jones, J. Tassello, and C. M. Rice. 2007. Alanine scanning of the hepatitis C virus core protein reveals numerous residues essential for production of infectious virus. J. Virol. 81:10220-10231.
35. Noppornpanth, S., T. X. Lien, Y. Poovorawan, S. L. Smits, A. D. Osterhaus, and B. L. Haagmans. 2006. Identification of a naturally occurring recombinant genotype 2/6 hepatitis C virus. J. Virol. 80:7569-7577. (Pubitemid 44092578)
36. Noppornpanth, S., S. L. Smits, T. X. Lien, Y. Poovorawan, A. D. Osterhaus, and B. L. Haagmans. 2007. Characterization of hepatitis C virus deletion mutants circulating in chronically infected patients. J. Virol. 81:12496-12503. (Pubitemid 350085863)
37. Okamoto, H., M. Kojima, S. Okada, H. Yoshizawa, H. Iizuka, T. Tanaka, E. E. Muchmore, D. A. Peterson, Y. Ito, and S. Mishiro. 1992. Genetic drift of hepatitis C virus during an 8.2-year infection in a chimpanzee: variability and stability. Virology 190:894-899.
38. Pekow, J. R., A. K. Bhan, H. Zheng, and R. T. Chung. 2007. Hepatic steatosis is associated with increased frequency of hepatocellular carcinoma in patients with hepatitis C-related cirrhosis. Cancer 109:2490-2496. (Pubitemid 46908652)
39. Pickart, C. M., and I. A. Rose. 1985. Ubiquitin carboxyl-terminal hydrolase acts on ubiquitin carboxyl-terminal amides. J. Biol. Chem. 260:7903-7910.
40. Pietschmann, T., A. Kaul, G. Koutsoudakis, A. Shavinskaya, S. Kallis, E. Steinmann, K. Abid, F. Negro, M. Dreux, F. L. Cosset, and R. Bartenschlager. 2006. Construction and characterization of infectious intragenotypic and intergenotypic hepatitis C virus chimeras. Proc. Natl. Acad. Sci. USA 103:7408-7413.
41. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.
42. Shavinskaya, A., S. Boulant, F. Penin, J. McLauchlan, and R. Bartenschlager. 2007. The lipid droplet binding domain of hepatitis C virus core protein is a major determinant for efficient virus assembly. J. Biol. Chem. 282:37158-37169.
43. Shepard, C. W., L. Finelli, and M. J. Alter. 2005. Global epidemiology of hepatitis C virus infection. Lancet Infect. Dis. 5:558-567.
44. Simmonds, P., J. Bukh, C. Combet, G. Deleage, N. Enomoto, S. Feinstone, P. Halfon, G. Inchauspe, C. Kuiken, G. Maertens, M. Mizokami, D. G. Murphy, H. Okamoto, J. M. Pawlotsky, F. Penin, E. Sablon, I. T. Shin, L. J. Stuyver, H. J. Thiel, S. Viazov, A. J. Weiner, and A. Widell. 2005. Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes. Hepatology 42:962-973. (Pubitemid 41401136)
45. Smith, D. B., S. Pathirana, F. Davidson, E. Lawlor, J. Power, P. L. Yap, and P. Simmonds. 1997. The origin of hepatitis C virus genotypes. J. Gen. Virol. 78(Pt. 2):321-328.
46. Steinmann, E., C. Brohm, S. Kallis, R. Bartenschlager, and T. Pietschmann. 2008. Efficient trans-encapsidation of hepatitis C virus RNAs into infectious virus-like particles. J. Virol. 82:7034-7046. (Pubitemid 351977723)
47. Suzuki, T., H. Aizaki, K. Murakami, I. Shoji, and T. Wakita. 2007. Molecular biology of hepatitis C virus. J. Gastroenterol. 42:411-423.
48. Tong, X., and B. A. Malcolm. 2006. Trans-complementation of HCV replication by non-structural protein 5A. Virus Res. 115:122-130. (Pubitemid 43088639)
49. Trinchet, J. C., N. Ganne-Carrie, P. Nahon, G. N'Kontchou, and M. Beaugrand. 2007. Hepatocellular carcinoma in patients with hepatitis C virus-related chronic liver disease. World J. Gastroenterol. 13:2455-2460.
50. Vassilaki, N., P. Friebe, P. Meuleman, S. Kallis, A. Kaul, G. Paranhos- Baccala, G. Leroux-Roels, P. Mavromara, and R. Bartenschlager. 2008. Role of the hepatitis C virus core+1 open reading frame and core cis-acting RNA elements in viral RNA translation and replication. J. Virol. 82:11503-11515.
51. Wakita, T., T. Pietschmann, T. Kato, T. Date, M. Miyamoto, Z. Zhao, K. Murthy, A. Habermann, H. G. Krausslich, M. Mizokami, R. Bartenschlager, and T. J. Liang. 2005. Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat. Med. 11:791-796.
52. Wang, T. H., R. C. Rijnbrand, and S. M. Lemon. 2000. Core protein-coding sequence, but not core protein, modulates the efficiency of cap-independent translation directed by the internal ribosome entry site of hepatitis C virus. J. Virol. 74:11347-11358.
53. Welbourn, S., R. Green, I. Gamache, S. Dandache, V. Lohmann, R. Bartenschlager, K. Meerovitch, and A. Pause. 2005. Hepatitis C virus NS2/3 processing is required for NS3 stability and viral RNA replication. J. Biol. Chem. 280:29604-29611.
54. Yagi, S., K. Mori, E. Tanaka, A. Matsumoto, F. Sunaga, K. Kiyosawa, and K. Yamaguchi. 2005. Identification of novel HCV subgenome replicating persistently in chronic active hepatitis C patients. J. Med. Virol. 77:399-413.
55. Yamaga, A. K., and J. H. Ou. 2002. Membrane topology of the hepatitis C virus NS2 protein. J. Biol. Chem. 277:33228-33234.
56. Zhang, J., O. Yamada, H. Yoshida, T. Iwai, and H. Araki. 2002. Autogenous translational inhibition of core protein: implication for switch from translation to RNA replication in hepatitis C virus. Virology 293:141-150. (Pubitemid 34936794)
57. Zhong, J., P. Gastaminza, G. Cheng, S. Kapadia, T. Kato, D. R. Burton, S. F. Wieland, S. L. Uprichard, T. Wakita, and F. V. Chisari. 2005. Robust hepatitis C virus infection in vitro. Proc. Natl. Acad. Sci. USA 102:9294-9299.